We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Integration of the Hamilton Microlab Star within HtL at AstraZeneca R&D Charnwood

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

AstraZeneca requires automation of multiple applications across different processes. The use of the flexible and modular Microlab® Star enables AstraZeneca to use one instrument for diverse applications ranging from compound dilution to assay construction.

Working closely with AstraZeneca, Hamilton have designed a system that has greater capacity and functionality than AstraZeneca’s previous machines, enabling them to carry out accurate dilutions.

The Microlab STAR’s features like “Dual Liquid Level Detection”, “Monitored Air Dipslacement” and the CO-RE technology have increased the process safety remarkably at AstraZeneca.

The Hamilton Software has been incorporated into the in-house sample management system, which has enabled full sample/data tracking and an increase in the speed of sample processing.

The Microlab STAR system shows a decrease in assay variability and an increase in throughput and accuracy. As a result the Microlab STAR has become the benchmark instrument within HtL at AstraZeneca R&D Charnwood.